Syndax Pharmaceuticals SNDX
$8.72 −$0.41 (-4.49%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.72 0.00%
Open$9.07
Prev close$9.13
Day range$8.69 – $9.27
Volume2.18M
Market cap$785.05M
P/E (TTM)–
Dividend yield–
SNDX Stock News
Headlines matching Syndax Pharmaceuticals or the SNDX ticker, most recent first.
- Citi Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $57
- H.C. Wainwright Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)
- Syndax Pharmaceuticals | SCHEDULE 13G: Others
- A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $26 to $57
- 10-Q: Syndax Pharmaceuticals | 10-Q: Q2 2026 Earnings Report
- 8-K: Syndax Pharmaceuticals | 8-K: Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update
- BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $26 Negative
- UBS Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $33 Negative
- Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $40
- J.P. Morgan Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $40 Negative
- BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $29
- Barclays Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $37
- TD Cowen Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating
- Goldman Sachs Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $34
- Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $46
No comments yet — be the first to weigh in on SNDX.
Sign in to join the discussion.